Strategy for prevention of cancers of the esophagus

Junichi Akiyama, Leo Alexandre, Anushka Baruah, Navtej Singh Buttar, Raghav Chandra, Allan B. Clark, Andrew R. Hart, Ernest Hawk, Daniela Kandioler, Sonja Kappel, Sheila K. Krishnadath, Anamay Sharma, Ishtpreet Singh, Danielle Straub, George Triadafilopoulos, Asad Umar, Brigitte Wolf

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the animal reflux-inflammation models for Barrett's esophagus and esophageal adenocarcinoma; genomic/epigenomic analyses; eflornithine-based combinations; the molecular derangements that promote neoplastic transformation; the role of COX-2 inhibitors, proton pump inhibitors, and phase II trials in Barrett's adenocarcinoma; statins in chemoprevention and treatment of esophageal cancer; and biomarkers as potential targets in Barrett's adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)108-126
Number of pages19
JournalAnnals of the New York Academy of Sciences
Volume1325
Issue number1
DOIs
StatePublished - Sep 1 2014

Fingerprint

Eflornithine
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Proton Pump Inhibitors
Cyclooxygenase 2 Inhibitors
Biomarkers
Esophageal Neoplasms
Animals
Adenocarcinoma
Barrett Esophagus
Chemoprevention
Epigenomics
Inflammation
Cancer
Therapeutics

Keywords

  • Animal reflux-inflammation models
  • Barrett's adenocarcinoma
  • Biomarkers
  • COXIBs, PPIs
  • Elofrnithine
  • OESO
  • Statins

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Akiyama, J., Alexandre, L., Baruah, A., Buttar, N. S., Chandra, R., Clark, A. B., ... Wolf, B. (2014). Strategy for prevention of cancers of the esophagus. Annals of the New York Academy of Sciences, 1325(1), 108-126. https://doi.org/10.1111/nyas.12529

Strategy for prevention of cancers of the esophagus. / Akiyama, Junichi; Alexandre, Leo; Baruah, Anushka; Buttar, Navtej Singh; Chandra, Raghav; Clark, Allan B.; Hart, Andrew R.; Hawk, Ernest; Kandioler, Daniela; Kappel, Sonja; Krishnadath, Sheila K.; Sharma, Anamay; Singh, Ishtpreet; Straub, Danielle; Triadafilopoulos, George; Umar, Asad; Wolf, Brigitte.

In: Annals of the New York Academy of Sciences, Vol. 1325, No. 1, 01.09.2014, p. 108-126.

Research output: Contribution to journalArticle

Akiyama, J, Alexandre, L, Baruah, A, Buttar, NS, Chandra, R, Clark, AB, Hart, AR, Hawk, E, Kandioler, D, Kappel, S, Krishnadath, SK, Sharma, A, Singh, I, Straub, D, Triadafilopoulos, G, Umar, A & Wolf, B 2014, 'Strategy for prevention of cancers of the esophagus', Annals of the New York Academy of Sciences, vol. 1325, no. 1, pp. 108-126. https://doi.org/10.1111/nyas.12529
Akiyama J, Alexandre L, Baruah A, Buttar NS, Chandra R, Clark AB et al. Strategy for prevention of cancers of the esophagus. Annals of the New York Academy of Sciences. 2014 Sep 1;1325(1):108-126. https://doi.org/10.1111/nyas.12529
Akiyama, Junichi ; Alexandre, Leo ; Baruah, Anushka ; Buttar, Navtej Singh ; Chandra, Raghav ; Clark, Allan B. ; Hart, Andrew R. ; Hawk, Ernest ; Kandioler, Daniela ; Kappel, Sonja ; Krishnadath, Sheila K. ; Sharma, Anamay ; Singh, Ishtpreet ; Straub, Danielle ; Triadafilopoulos, George ; Umar, Asad ; Wolf, Brigitte. / Strategy for prevention of cancers of the esophagus. In: Annals of the New York Academy of Sciences. 2014 ; Vol. 1325, No. 1. pp. 108-126.
@article{06c03434088744f5929fceca360c762a,
title = "Strategy for prevention of cancers of the esophagus",
abstract = "The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the animal reflux-inflammation models for Barrett's esophagus and esophageal adenocarcinoma; genomic/epigenomic analyses; eflornithine-based combinations; the molecular derangements that promote neoplastic transformation; the role of COX-2 inhibitors, proton pump inhibitors, and phase II trials in Barrett's adenocarcinoma; statins in chemoprevention and treatment of esophageal cancer; and biomarkers as potential targets in Barrett's adenocarcinoma.",
keywords = "Animal reflux-inflammation models, Barrett's adenocarcinoma, Biomarkers, COXIBs, PPIs, Elofrnithine, OESO, Statins",
author = "Junichi Akiyama and Leo Alexandre and Anushka Baruah and Buttar, {Navtej Singh} and Raghav Chandra and Clark, {Allan B.} and Hart, {Andrew R.} and Ernest Hawk and Daniela Kandioler and Sonja Kappel and Krishnadath, {Sheila K.} and Anamay Sharma and Ishtpreet Singh and Danielle Straub and George Triadafilopoulos and Asad Umar and Brigitte Wolf",
year = "2014",
month = "9",
day = "1",
doi = "10.1111/nyas.12529",
language = "English (US)",
volume = "1325",
pages = "108--126",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Strategy for prevention of cancers of the esophagus

AU - Akiyama, Junichi

AU - Alexandre, Leo

AU - Baruah, Anushka

AU - Buttar, Navtej Singh

AU - Chandra, Raghav

AU - Clark, Allan B.

AU - Hart, Andrew R.

AU - Hawk, Ernest

AU - Kandioler, Daniela

AU - Kappel, Sonja

AU - Krishnadath, Sheila K.

AU - Sharma, Anamay

AU - Singh, Ishtpreet

AU - Straub, Danielle

AU - Triadafilopoulos, George

AU - Umar, Asad

AU - Wolf, Brigitte

PY - 2014/9/1

Y1 - 2014/9/1

N2 - The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the animal reflux-inflammation models for Barrett's esophagus and esophageal adenocarcinoma; genomic/epigenomic analyses; eflornithine-based combinations; the molecular derangements that promote neoplastic transformation; the role of COX-2 inhibitors, proton pump inhibitors, and phase II trials in Barrett's adenocarcinoma; statins in chemoprevention and treatment of esophageal cancer; and biomarkers as potential targets in Barrett's adenocarcinoma.

AB - The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the animal reflux-inflammation models for Barrett's esophagus and esophageal adenocarcinoma; genomic/epigenomic analyses; eflornithine-based combinations; the molecular derangements that promote neoplastic transformation; the role of COX-2 inhibitors, proton pump inhibitors, and phase II trials in Barrett's adenocarcinoma; statins in chemoprevention and treatment of esophageal cancer; and biomarkers as potential targets in Barrett's adenocarcinoma.

KW - Animal reflux-inflammation models

KW - Barrett's adenocarcinoma

KW - Biomarkers

KW - COXIBs, PPIs

KW - Elofrnithine

KW - OESO

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=84925060391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925060391&partnerID=8YFLogxK

U2 - 10.1111/nyas.12529

DO - 10.1111/nyas.12529

M3 - Article

C2 - 25266020

AN - SCOPUS:84925060391

VL - 1325

SP - 108

EP - 126

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - 1

ER -